Cigna Corporation (CI) Earnings History
Annual and quarterly earnings data from 1989 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 10.5% | 3.8% | 1.4% |
| 2023 | 12.9% | 4.4% | 2.6% |
| 2022 | 13.0% | 4.7% | 3.7% |
| 2021 | 13.2% | 4.6% | 3.1% |
| 2020 | 15.1% | 5.1% | 5.3% |
Download Data
Export CI earnings history in CSV or JSON format
Free sign-in required to download data
Cigna Corporation (CI) Earnings Overview
As of February 28, 2026, Cigna Corporation (CI) reported trailing twelve-month net income of $6.15B, reflecting -0.3% year-over-year growth. The company earned $22.92 per diluted share over the past four quarters, with a net profit margin of 0.0%.
Looking at the long-term picture, CI's 5-year EPS compound annual growth rate (CAGR) stands at -2.0%, signaling declining earnings. The company achieved its highest annual net income of $8.46B in fiscal 2020.
Cigna Corporation maintains positive profitability with a gross margin of 0.1%, operating margin of 0.0%, and net margin of 0.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including UNH ($14.23B net income, 0.0% margin), CVS ($1.77B net income, 0.0% margin), CI has room to improve margins relative to the peer group. Compare CI vs UNH →
Peer Comparison
Earnings metrics vs industry competitors
| Company | TTM Net Income | TTM EPS | Net Margin | ROE | YoY Growth | Compare |
|---|---|---|---|---|---|---|
CICurrent | $6.1B | $22.92 | 0.0% | 0.1% | -0.3% | — |
UNH | $14.2B | $15.63 | 0.0% | 0.1% | +0.0% | |
CVS | $1.8B | $1.38 | 0.0% | 0.0% | -0.6% |
Historical Data
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $3.43B | -33.5% | $9.42B | $12.12 | 1.4% | 3.8% |
| 2023 | $5.16B | -23.0% | $8.54B | $17.39 | 2.6% | 4.4% |
| 2022 | $6.70B | +24.8% | $8.45B | $21.41 | 3.7% | 4.7% |
| 2021 | $5.37B | -36.5% | $7.94B | $15.75 | 3.1% | 4.6% |
| 2020 | $8.46B | +65.7% | $8.15B | $22.96 | 5.3% | 5.1% |
| 2019 | $5.10B | +93.6% | $8.08B | $13.44 | 3.3% | 5.3% |
| 2018 | $2.64B | +17.9% | $4.16B | $10.54 | 5.4% | 8.6% |
| 2017 | $2.24B | +19.8% | $3.94B | $9.17 | 5.4% | 9.4% |
| 2016 | $1.87B | -10.8% | $3.09B | $7.19 | 4.7% | 7.8% |
| 2015 | $2.09B | -0.4% | $12.36B | $8.04 | 5.5% | 32.6% |
See CI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CI Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CI vs AGIO
See how CI stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is CI growing earnings?
CI EPS of $22.92 reflects slowing growth at -0.3%, below the 5-year CAGR of -2.0%. TTM net income is $6.1B. Expansion rate has moderated.
What are CI's profit margins?
Cigna Corporation net margin is +0.0%, with operating margin at +0.0%. Below-average margins reflect competitive or cost pressures.
How consistent are CI's earnings?
CI earnings data spans 1989-2024. The current earnings trend is -0.3% YoY. Historical data enables comparison across business cycles.